BMCS BioTech Medics Inc (PK)

BioTech Medics, Inc., (PINKSHEETS: BMCS) announced today the recent survey conducted by the National Institutes of Health and the US Centers for Disease Control and Prevention found that "about four in 10 US adults are turning to alternative medical approaches for chronic pain." This independent study substantiates more Americans are turning to alternative medicine similar to that offered by BioTech Pain Management & Wellness Centers for pain relief.

Keith Houser, CEO of BioTech, said, "Back pain was the leading reason that Americans reported using alternative medicine techniques, followed by neck, joint and arthritic pain, the survey said. I myself became involved with high powered deep penetrating laser therapy due to back pain."

The NIH Survey also found that "many people feel alternative medicine may work better for them than typical medical approaches, with fewer bad side effects."

"As I look at this data, what I'm most struck with is how much people are turning to CAM (complementary and alternative medicine) approaches as part of the management of chronic pain conditions, particularly chronic back pain, but also neck pain and musculoskeletal pain and headache," said Dr. Josephine Briggs, director of the US National Center for Complementary and Alternative Medicine at the NIH.

The 2007 survey results were based on responses from 23,000 adults nationwide.

Overall, women and people with higher levels of education were more likely to use alternative medicine techniques, the survey concluded.

BioTech Medics has developed proprietary pain management protocols utilizing patented FDA 510(k) cleared high powered deep penetrating medical therapeutic lasers for reducing or eliminating muscular, skeletal, nerve and/or arthritic pain. The procedures are drug-free, quick (15 to 30 minutes) safe and non-invasive. BioTech has affiliated centers operating in Dallas, Kansas City (Overland Park), Albuquerque and Santa Fe, NM. A new center is pending in Newport Beach, CA.

BioTech's advantage over competition is their proprietary protocols for the high-powered therapeutic medical lasers that the patient feels healing their body.

Safe Harbor for Forward-Looking Statements.

This release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"). Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. This is not an offer to buy or sell any security.

Contact: Investor Relations 972-274-5533